PMID- 11340638 OWN - NLM STAT- MEDLINE DCOM- 20010719 LR - 20131121 IS - 0360-4012 (Print) IS - 0360-4012 (Linking) VI - 64 IP - 4 DP - 2001 May 15 TI - In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups. PG - 322-30 AB - The transcription factor Nurr1, an orphan member of the steroid-thyroid hormone nuclear receptor superfamily, is essential for the proper terminal differentiation of ventral midbrain dopaminergic neurons. Disruption of the Nurr1 gene in mice by homologous recombination abolishes synthesis of dopamine (DA) and expression of DA biosynthetic enzymes, including tyrosine hydroxylase (TH), in the ventral midbrain without affecting the synthesis of DA in other areas of the brain. At birth, however, dopaminergic neuron precursors in Nurr1 null (-/-) pups remain as shown by continued expression of residual, untranslated Nurr1 mRNA not altered by homologous recombination. Since Nurr1 disruption is lethal shortly after birth, to further investigate the developmental properties of these neurons, dissociated ventral midbrain neurons from newborn pups were grown for 5 days on an astrocyte feeder layer, subjected to various treatments and then evaluated for expression of TH by fluorescent immunocytochemistry. Initially, a small percentage of neurons (0.26% +/- 0.07%) from the ventral midbrain of Nurr1 -/- pups were TH-immunoreactive (TH-IR). No change in TH expression was observed in the presence of glial cell line-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), or DA alone or in combination. Treatment with forskolin (Fsk), however, significantly increased the percentage of TH-IR neurons (1.36% +/- 0.15%). Combination of Fsk, BNDF, and DA further increased the percentage of TH-IR neurons (2.58% +/- 0.50%). Therefore, these data suggest that dopaminergic neuron precursors, which develop in vivo without Nurr1, remain in an undifferentiated condition that is permissive to the induction of TH in vitro. J. Neurosci. Res. 64:322-330, 2001. Published 2001 Wiley-Liss, Inc. FAU - Eells, J B AU - Eells JB AD - National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. FAU - Rives, J E AU - Rives JE FAU - Yeung, S K AU - Yeung SK FAU - Nikodem, V M AU - Nikodem VM LA - eng PT - Journal Article PL - United States TA - J Neurosci Res JT - Journal of neuroscience research JID - 7600111 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Cardiotonic Agents) RN - 0 (DNA-Binding Proteins) RN - 0 (Gdnf protein, mouse) RN - 0 (Glial Cell Line-Derived Neurotrophic Factor) RN - 0 (Microtubule-Associated Proteins) RN - 0 (Nerve Growth Factors) RN - 0 (Nerve Tissue Proteins) RN - 0 (Neuroprotective Agents) RN - 0 (Nr4a2 protein, mouse) RN - 0 (Nuclear Receptor Subfamily 4, Group A, Member 2) RN - 0 (Transcription Factors) RN - 1F7A44V6OU (Colforsin) RN - EC 1.14.16.2 (Tyrosine 3-Monooxygenase) RN - VTD58H1Z2X (Dopamine) SB - IM MH - Animals MH - Animals, Newborn MH - Astrocytes/drug effects/metabolism MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cardiotonic Agents/pharmacology MH - Cells, Cultured MH - Colforsin/*pharmacology MH - *DNA-Binding Proteins MH - Dopamine/*pharmacology MH - Glial Cell Line-Derived Neurotrophic Factor MH - Mesencephalon/drug effects/metabolism MH - Mice MH - Mice, Mutant Strains MH - Microtubule-Associated Proteins/metabolism MH - *Nerve Growth Factors MH - Nerve Tissue Proteins/pharmacology MH - Neurons/*drug effects/metabolism MH - Neuroprotective Agents/*pharmacology MH - Nuclear Receptor Subfamily 4, Group A, Member 2 MH - Transcription Factors/*deficiency/genetics MH - Tyrosine 3-Monooxygenase/*drug effects/metabolism EDAT- 2001/05/08 10:00 MHDA- 2001/07/20 10:01 CRDT- 2001/05/08 10:00 PHST- 2001/05/08 10:00 [pubmed] PHST- 2001/07/20 10:01 [medline] PHST- 2001/05/08 10:00 [entrez] AID - 10.1002/jnr.1082 [doi] PST - ppublish SO - J Neurosci Res. 2001 May 15;64(4):322-30. doi: 10.1002/jnr.1082.